Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bebo HealthXPAR:MLBBO 47 ROC (Joel Greenblatt) % is 90.36% as of Dec. 2025, which is 1263% above its 10-year median of 6.63. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,126 Retail - Cyclical companies, Bebo Health ranks better than 89.43% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Bebo Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 90.36%.
The historical rank and industry rank for Bebo Health's ROC (Joel Greenblatt) % or its related term are showing as below:
XPAR:MLBBO'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -0.66 Med: 6.63 Max: 361.11
Current: 56.38
During the past 7 years, Bebo Health's highest ROC (Joel Greenblatt) % was 361.11%. The lowest was -0.66%. And the median was 6.63%.
XPAR:MLBBO's ROC (Joel Greenblatt) % is ranked better than 89.43% of 1126
companies
in the Retail - Cyclical industry
Industry Median: 11.57
vs XPAR:MLBBO: 56.38
Bebo Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
Bebo Health (XPAR:MLBBO) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Bebo Health ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Bebo Health's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, DKS: ROC (Joel Greenblatt) % Comparison
For the Specialty Retail subindustry, Bebo Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health ROC (Joel Greenblatt) % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Bebo Health's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is one times the annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 90.36% mean?
Bebo Health (XPAR:MLBBO) has a ROC (Joel Greenblatt) % of 90.36% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Bebo Health and its competitors. This is 1263% above median its historical median of 6.63. According to the industry distribution chart, Bebo Health ranks #119 out of 1126 companies in the Retail - Cyclical industry, placing it in the top 10.6%.
Is Bebo Health's ROC (Joel Greenblatt) % too high?
Bebo Health's current ROC (Joel Greenblatt) % of 90.36% is 1263% above median its 10-year median of 6.63. The Retail - Cyclical industry median ROC (Joel Greenblatt) % is 11.57. Bebo Health's value of 90.36% is 681% above this industry median. Based on the distribution chart, Bebo Health ranks #119 out of 1126 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's ROC (Joel Greenblatt) % compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #119 out of 1126 companies for ROC (Joel Greenblatt) %. This places Bebo Health in the top 11% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 11.57. Bebo Health's value of 90.36% is 681% above this benchmark. While the company's 10-year median is 6.63 vs. the industry median of 11.57, Bebo Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Retail - Cyclical company?
The median ROC (Joel Greenblatt) % among Retail - Cyclical companies is 11.57, based on 1,126 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current ROC (Joel Greenblatt) % of 90.36% is 681% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median ROC (Joel Greenblatt) % is 11.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current ROC (Joel Greenblatt) % is 90.36%, which is 1263% above median its own 10-year median of 6.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.18 — trading 513.3% above its estimated fair value. The current ROC (Joel Greenblatt) % is 90.36%, which is 1263% above median its 10-year median of 6.63 and 681% above the Retail - Cyclical industry median of 11.57. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current ROC (Joel Greenblatt) % is 90.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.18 is trading 513.3% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
ROC (Joel Greenblatt) %: 90.36% (1263% above median its 10-year median of 6.63)
GF Value™: €0.03 vs. price of €0.18 (513.3% above fair value)
Industry Position: 681% above the Retail - Cyclical median (#119 of 1126)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 
